Botanical guide · Ingredient reference

Chaparral: liver risk outweighs unsupported treatment promises

A safety-focused look at chaparral tea, extracts and claims based on laboratory research.

Read the evidence ↓

Supplement Science Insights Editorial Team

Published September 23, 2026

What the research addresses

Chaparral is a desert plant traditionally used in teas and other remedies. MSK describes severe liver injury associated with chaparral-containing products, including cases requiring transplantation. Laboratory research on its constituent NDGA does not establish that taking chaparral is an effective treatment. [1]

What the finding does not establish

MSK reports that a clinical cancer study found chaparral ineffective. Findings about an isolated compound, an animal model or a topical preparation do not establish a useful role for an oral tea or capsule. [1]

Why a reassuring anecdote is not a safety study

Imagine a seller points to several people who drank a tea and felt fine. That observation cannot rule out an uncommon but severe adverse effect. To estimate risk, we would need to know how many people used a defined preparation, for how long, and how systematically harms were assessed.

The same reasoning applies to “used for centuries.” The phrase describes a history of use, not a count of monitored exposures or a reliable estimate of liver injury. When the proposed benefit is unproven and serious harm is documented, absence of a precise risk percentage is not a reason to assume safety.

Hypothetical example — illustrates evidence interpretation; not a product or dose recommendation.
Hypothetical finding or choiceWhat it means
Several users report no symptomsCannot exclude uncommon severe injury
Laboratory activity of NDGADoes not establish oral chaparral benefit
Traditional useDoes not quantify a safe dose or duration

Safety and treatment considerations

Do not use chaparral as a self-directed treatment. Its liver-injury reports include irreversible harm. A small report without observed adverse effects cannot define a safe exposure or cancel the serious reports; the relation between exposure length and risk remains uncertain. [1]

A practical next step

This article provides no chaparral dose or product recommendation. If you already use it, tell your clinician the preparation, amount and duration rather than relying on a detox or antioxidant claim.

Chaparral: liver risk outweighs unsupported treatment promises — original article outline diagram
Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

Sources for this article

  1. Memorial Sloan Kettering Cancer Center — Chaparral
    Source consulted: 2026-09-17. This is a reference resource, not a claim that we conducted the studies or tested a product.